HbA1c
- Capillary Electrophoresis
- Diabetes
EurA1c trial
The mission of the IFCC-EUBD is education on the use of biomarkers in diabetes, especially on improving quality of the assay of HbA1c. External Quality Assessment (Proficiency Testing) is a powerful tool to monitor the quality of tests in the medical laboratory.
The EurA1c trial, organized yearly, investigates the performance of HbA1c assays across countries and manufacturers. EQA organisers of different countries use the same two samples either in their regular EQA program or stand-alone. Results of all countries are evaluated and presented in terms of performances per country and per manufacturer. The trial has Eurocentric roots but, in the meantime, also non-European countries are participating.
Since 2016, Sebia instruments have demonstrated excellent performances for both whole blood and lyophilised samples.
Furthermore, the number of Sebia instruments participating in this important EQA has tremendously increased over these past years, demonstrating the adoption of this technique by the laboratories, as the technique of choice for an accurate and robust HbA1c measurement.
Test associated with this resource
Related instruments
Capillary Electrophoresis solution to meet your high capacity needs.
A concentrate of Sebia’s expertise in a high throughput instrument.
Evolution makes the difference.
The compact and affordable automation of Capillary Electrophoresis.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.